Cardiovascular Disease Doctors in Mayfield Hts, OH Accepting Medicare

5 Cardiovascular Disease doctors found. Showing 1 - 5

Dr. Vijay G Mistry, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6770 Mayfield Rd # 425, Mayfield Hts, OH 44124 Phone: 440-442-2040    Fax: 440-460-2807

Michael A Hanna, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6770 Mayfield Rd Ste 333, Mayfield Hts, OH 44124 Phone: 440-461-0038    Fax: 440-461-8820

Avrum G Jacobs, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6801 Mayfield Rd, Suite 444, Mayfield Hts, OH 44124 Phone: 440-449-8890

Assad E Rizk, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 6770 Mayfield Rd Ste 333, Mayfield Hts, OH 44124 Phone: 440-461-0038    Fax: 440-461-8820

Mr. Abdalla Ezziddin, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 6770 Mayfield Rd Ste 333, Mayfield Hts, OH 44124 Phone: 440-461-0038    Fax: 440-461-8820

News Archive

FDA Approves Pre-Filled Pre-Mixed Fertility Medication

The U.S. Food and Drug Administration (FDA) today announced approval of Follistim®-AQ TM cartridge (follitropin beta injection) in the United States. Follistim-AQ cartridge is the first follicle stimulating hormone (FSH) treatment available in a pre-filled, pre-mixed solution, eliminating the need for patients to mix one or more vials of medication.

Researchers create new material with antifungal and antitumor properties

A new material with antifungal and antitumor properties has been developed by researchers at the Center for Development of Functional Materials (CDMF), one of the Research, Innovation and Dissemination Centers (RIDCs) supported by São Paulo Research Foundation - FAPESP.

Study demonstrates potential of nontoxic envelope proteins as an alternative to pseudotype lentiviral vectors

Therapeutic lentiviral vectors are emerging as vital tools for molecular medicine as evidenced by the growing number of clinical trials using these vector systems. From a basic research standpoint, lentiviral vectors are very intriguing substrates. On the one hand, the HIV-1 genome offers expanded cloning capacity and the capability to transduce nondividing cells such as hematopoietic stem cells (HSCs) and neurons.

Brigham and Women's, and UI Hospitals and Clinics begin certification for SynCardia artificial heart implantation

SynCardia Systems, Inc. announced today that Brigham and Women's Hospital in Boston, and University of Iowa (UI) Hospitals and Clinics in Iowa City, Iowa, have begun certification to implant the SynCardia temporary Total Artificial Heart. Brigham and Women's will complete Phase I of certification on Nov. 1 & 2, and UI Hospitals and Clinics completed Phase I on Oct. 21 & 22.

Read more Medical News

› Verified 8 days ago